Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hartmut Goldschmidt

Showing results (201-210 of 539) with videos related to

Pageof 54
Sort By:
Acta Radiologica (Stockholm, Sweden : 1987)|April 19, 2011
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and diffusion-weighted imaging of bone marrow in healthy individualsJens Hillengass, Bram Stieltjes, Tobias Bäuerle, et al.
Haematologica|October 26, 2010
Efficacy and outcome of autologous transplantation in rare myelomasCurly Morris, Mary Drake, Jane Apperley, et al.
Clinical Epigenetics|October 5, 2018
PRC2 targeting is a therapeutic strategy for EZ score defined high-risk multiple myeloma patients and overcome resistance to IMiDsLaurie Herviou, Alboukadel Kassambara, Stéphanie Boireau, et al.
Oncotarget|December 13, 2017
Lenalidomide overcomes the immunosuppression of regulatory CD8<sup>+</sup>CD28<sup>-</sup> T-cellsBrigitte Neuber, Jingying Dai, Wjahat A Waraich, et al.
Diagnostics (Basel, Switzerland)|October 16, 2025
AI-Based 3D-Segmentation Quantifies Sarcopenia in Multiple Myeloma PatientsThuy-Duong Do, Tobias Nonnenmacher, Marieke Burghardt, et al.
Cancer|June 22, 2010
The efficacy and safety of lenalidomide plus dexamethasone in relapsed and/or refractory multiple myeloma patients with impaired renal functionMeletios Dimopoulos, Adrian Alegre, Edward A Stadtmauer, et al.
Frontiers in Oncology|May 8, 2023
Impact of novel agent therapies on immune cell subsets and infectious complications in patients with relapsed/refractory multiple myelomaLukas John, Kaya Miah, Axel Benner, et al.
Cells|January 8, 2023
Investigation of Rare Non-Coding Variants in Familial Multiple MyelomaYasmeen Niazi, Nagarajan Paramasivam, Joanna Blocka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 16, 2009
Dynamic contrast-enhanced magnetic resonance imaging identifies a subgroup of patients with asymptomatic monoclonal plasma cell disease and pathologic microcirculationJens Hillengass, Christian Zechmann, Tobias Bäuerle, et al.
Radiology|August 26, 2009
Multiple myeloma and monoclonal gammopathy of undetermined significance: importance of whole-body versus spinal MR imagingTobias Bäuerle, Jens Hillengass, Kerstin Fechtner, et al.
Pageof 54

Showing results (201-210 of 539) with videos related to

Sort By:
Pageof 54
Acta Radiologica (Stockholm, Sweden : 1987)|April 19, 2011
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and diffusion-weighted imaging of bone marrow in healthy individualsJens Hillengass, Bram Stieltjes, Tobias Bäuerle, et al.
Haematologica|October 26, 2010
Efficacy and outcome of autologous transplantation in rare myelomasCurly Morris, Mary Drake, Jane Apperley, et al.
Clinical Epigenetics|October 5, 2018
PRC2 targeting is a therapeutic strategy for EZ score defined high-risk multiple myeloma patients and overcome resistance to IMiDsLaurie Herviou, Alboukadel Kassambara, Stéphanie Boireau, et al.
Oncotarget|December 13, 2017
Lenalidomide overcomes the immunosuppression of regulatory CD8<sup>+</sup>CD28<sup>-</sup> T-cellsBrigitte Neuber, Jingying Dai, Wjahat A Waraich, et al.
Diagnostics (Basel, Switzerland)|October 16, 2025
AI-Based 3D-Segmentation Quantifies Sarcopenia in Multiple Myeloma PatientsThuy-Duong Do, Tobias Nonnenmacher, Marieke Burghardt, et al.
Cancer|June 22, 2010
The efficacy and safety of lenalidomide plus dexamethasone in relapsed and/or refractory multiple myeloma patients with impaired renal functionMeletios Dimopoulos, Adrian Alegre, Edward A Stadtmauer, et al.
Frontiers in Oncology|May 8, 2023
Impact of novel agent therapies on immune cell subsets and infectious complications in patients with relapsed/refractory multiple myelomaLukas John, Kaya Miah, Axel Benner, et al.
Cells|January 8, 2023
Investigation of Rare Non-Coding Variants in Familial Multiple MyelomaYasmeen Niazi, Nagarajan Paramasivam, Joanna Blocka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 16, 2009
Dynamic contrast-enhanced magnetic resonance imaging identifies a subgroup of patients with asymptomatic monoclonal plasma cell disease and pathologic microcirculationJens Hillengass, Christian Zechmann, Tobias Bäuerle, et al.
Radiology|August 26, 2009
Multiple myeloma and monoclonal gammopathy of undetermined significance: importance of whole-body versus spinal MR imagingTobias Bäuerle, Jens Hillengass, Kerstin Fechtner, et al.
Pageof 54